Diana Hausman
CHIEF MEDICAL OFFICER
Drug Development and Management
Zymeworks
Canada
Biography
DIANA HAUSMAN, MD, has served as our Chief Medical Officer since January 2012. Prior to that, she served as our Vice President, Clinical Development from 2009 until January 2012. Dr. Hausman held a number of clinical research positions at ZymoGenetics, Inc. from 2005 to 2009, most recently as Senior Director of Clinical Research with responsibility for all therapeutic areas, including oncology, autoimmune disease and virology. Prior to Zymogenetics, Dr. Hausman was at Berlex in Seattle from 2002 to 2005, where she led a global drug development team. Dr. Hausman received her training in medical oncology from the University of Washington, and holds an M.D. degree from the University of Pennsylvania and an A.B. in Biology from Princeton University.
Research Interest
drug development and management